Foghorn Therapeutics | ARS: Annual Report to Security Holders
May 3 08:06 ET
Foghorn Therapeutics | DEFA14A: Others
May 3 08:06 ET
Foghorn Therapeutics | DEF 14A: Definitive information statements
May 3 08:06 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Humer Kristian
Apr 17 16:06 ET
Foghorn Therapeutics | 3: Initial statement of beneficial ownership of securities-Officer Humer Kristian
Apr 17 16:05 ET
Foghorn Therapeutics | 8-K: Current report
Apr 16 07:05 ET
Foghorn Therapeutics | 8-K: Current report
Apr 9 16:46 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalie Fanny
Mar 12 16:24 ET
Foghorn Therapeutics | 8-K: Current report
Mar 7 07:14 ET
Foghorn Therapeutics | 10-K: Annual report
Mar 7 07:14 ET
Foghorn Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(6.656%),Abigail P. Johnson(6.656%)
Feb 9 09:10 ET
Foghorn Therapeutics | 8-K: Current report
Feb 8 07:10 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer GOTTSCHALK ADRIAN
Jan 25 16:11 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cardama Alfonso Quintas
Jan 25 16:06 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Cavalie Fanny
Jan 25 16:06 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Costa Carlos
Jan 25 16:06 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bellon Steven F.
Jan 25 16:06 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer LaCascia Michael
Jan 25 16:05 ET
Foghorn Therapeutics | 8-K: Current report
Jan 17 00:00 ET
Foghorn Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reine Allan
Jan 17 00:00 ET
No Data
No Data